During the time period studied in this analysis, three anti-TNF agents were available in the UK: infliximab, etanercept and adalimumab. A comparison cohort of biological-naive RA patients was ...

Objective To evaluate the impact of methotrexate (MTX) dosage on clinical, functional and quality of life outcomes in patients with rheumatoid arthritis (RA) from two previous etanercept (ETN) trials ...

The transcriptome data and clinical data in GSE13026, GSE21537, and GSE45867 were downloaded to explore the relationships between ATF3 expression and RA status, lymphocyte aggregation, inflammation ...

charite.de Objectives To assess whether combination therapy with infliximab (IFX) plus nonsteroidal anti-inflammatory drugs (NSAIDs) is superior to NSAID monotherapy for reaching Assessment of ...

uz.kuleuven.ac.be Background and aims: This study evaluates the long-term safety of infliximab in patients with inflammatory bowel disease (IBD) treated with the drug over a 14-year period. Methods: ...

uz.kuleuven.be Background and aims: This observational study assessed the long-term clinical benefit of infliximab (IFX) in 614 consecutive patients with Crohn’s disease (CD) from a single centre ...

Patients were treated for a median of 4 years (for both). The biologics were adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, ustekinumab, guselkumab, tildrakizumab, risankizumab ...

Against an increased risk USA/Canada 1152 biologic users versus 7306 MTX users Retrospective cohort study Infliximab, etanercept and adalimumab. Pooled hazard ratio for hematologic malignancy ...

Multiple TNF-blocking agents are now available, in both subcutaneous and intravenous formulations. The intervals of treatment are different for these agents: etanercept once a week, adalimumab once ...

Starjemza gains FDA approval as the eighth ustekinumab biosimilar, enhancing treatment options for rheumatic and gastrointestinal conditions. The FDA has approved Starjemza (ustekinumab-hmny) as a ...

e23.jp Background To evaluate long-term efficacy of infliximab (IFX) in refractory uveoretinitis associated with Behçet’s disease (BD) depending on uveoretinitis duration. Methods Records of 16 ...